Shareholder Information

Download Documentation Investor Presentation
Cambrex at UBS Global Healthcare ConferenceMonday, May 18, 2015 9:30 a.m. ETDownload Event Supporting Material UBS Global Healthcare Conference Presentation

Q1 2015 Cambrex Earnings Conference CallFriday, May 1, 2015 8:30 a.m. ET

About Cambrex

Cambrex Corporation is a custom development and manufacturing organization that specializes in products and services that accelerate the development and commercialization of small molecule therapeutics.

We offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals.

Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage forms.

Stock Quote

CBM (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Up 0.06 (0.15%)
Data as of 05/21/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Stock Chart

Stock chart for: 03NA000000CBM

Recent News more

05/11/15 - 12:14 p.m.
Cambrex To Present At UBS Global Healthcare Conference
05/01/15 - 7:00 a.m.
Cambrex Reports First Quarter 2015 Financial Results
04/29/15 - 12:01 p.m.
Cambrex To Announce First Quarter 2015 Financial Results On May 1, 2015
04/29/15 - 8:06 a.m.
Cambrex to Present at the Deutsche Bank 40th Annual Healthcare Conference

Upcoming Eventsmore

There are currently no events scheduled.

Contact Information

Stephanie LaFiura
Investors Relations Associate
Phone: 201-804-3037
Fax: 201-804-9852

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: 718.921.8275
Fax: 718.921.8331

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.